NCT05888389

Brief Summary

A prospective, multicenter, randomized controlled trial is designed to evaluate the safety of nerve block anesthesia combined with sedative anesthesia versus general anesthesia during burr hole craniostomy with drainage for chronic subdural hematoma.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
190

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 7, 2023

Completed
29 days until next milestone

First Posted

Study publicly available on registry

June 5, 2023

Completed
10 months until next milestone

Study Start

First participant enrolled

April 1, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

April 22, 2024

Status Verified

April 1, 2024

Enrollment Period

1.2 years

First QC Date

May 7, 2023

Last Update Submit

April 19, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of intraoperative body movement

    Intraoperative body movement is defined as those likely to interfere with surgical procedures such as bending of hand and/or leg and movement of head.

    During the surgery

Secondary Outcomes (5)

  • Neurological function

    at discharge and 6 months after operation

  • Recurrence rate at 6 months after surgery

    From operation up to 6 months postoperatively

  • Conversion to general anesthesia

    During the surgery

  • Intraoperative awareness

    1 day after surgery

  • Postoperative delirium

    1-5 days after surgery

Study Arms (2)

General anesthesia (GA)

ACTIVE COMPARATOR

The GA group will receive general anesthesia.

Procedure: General Anesthesia

Cranial nerve block anesthesia combined with sedative anesthesia (CNB-D)

EXPERIMENTAL

The CNB-D group will receive cranial nerve block anesthesia combined with sedative anesthesia

Procedure: Cranial Nerve Block Anesthesia Combined With Sedative Anesthesia

Interventions

Patients in the nerve block anesthesia combined with sedative anesthesia group will first receive cranial nerve blocks under standard monitoring. At the same time, intravenous dexmedetomidine infusion is started for sedation at a rate of 2-4ug/kg for 10 minutes, followed by a continuous infusion of 0.5-1ug/kg/h until the Richmond Agitation-Sedation Scale (RASS) of -3.

Cranial nerve block anesthesia combined with sedative anesthesia (CNB-D)

Patients will be induced with propofol or etomidate, sufentanil , rocuronium or cisatracurium .

General anesthesia (GA)

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with chronic subdural hematoma with preoperative neurological dysfunction for burr hole drainage;
  • Age beween 18 to 80
  • Chronic subdural hematoma verified on cranial computed tomography or magnetic resonance imaging with hematoma thickness \>1.0cm or midline shift \>1.0 cm.
  • Written informed consent obtained

You may not qualify if:

  • Preoperative unconsciousness (Glasgow Coma Scale\<13, or Markwalder Grade 2-4) or cognitive dysfunction (Mini-Cog≤3, or MMSE≤20)
  • Preoperative sensory or motor aphasia
  • Recurrence of hematoma with previous surgery for chronic subdural hematoma.
  • Previous intracranial surgery or with intracranial lesion
  • with severe comorbidity or other organ dysfunction
  • Allergic to anesthetics
  • Severe coagulopathy or high risk of life-threatening bleeding
  • Participating in another research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tiantan Hospital, Capital Medical University

Beijing, Beijing Municipality, 100050, China

RECRUITING

Related Publications (3)

  • Wong HM, Woo XL, Goh CH, Chee PHC, Adenan AH, Tan PCS, Wong ASH. Chronic Subdural Hematoma Drainage Under Local Anesthesia with Sedation versus General Anesthesia and Its Outcome. World Neurosurg. 2022 Jan;157:e276-e285. doi: 10.1016/j.wneu.2021.10.074. Epub 2021 Oct 11.

    PMID: 34648987BACKGROUND
  • Ashry A, Al-Shami H, Gamal M, Salah AM. Local anesthesia versus general anesthesia for evacuation of chronic subdural hematoma in elderly patients above 70 years old. Surg Neurol Int. 2022 Jan 12;13:13. doi: 10.25259/SNI_425_2021. eCollection 2022.

    PMID: 35127213BACKGROUND
  • Liu HY, Yang LL, Dai XY, Li ZP. Local anesthesia with sedation and general anesthesia for the treatment of chronic subdural hematoma: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2022 Mar;26(5):1625-1631. doi: 10.26355/eurrev_202203_28230.

    PMID: 35302209BACKGROUND

MeSH Terms

Conditions

Hematoma, Subdural, Chronic

Interventions

Anesthesia, General

Condition Hierarchy (Ancestors)

Hematoma, SubduralIntracranial Hemorrhage, TraumaticIntracranial HemorrhagesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemVascular DiseasesCardiovascular DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsHematomaHemorrhageWounds and Injuries

Intervention Hierarchy (Ancestors)

AnesthesiaAnesthesia and Analgesia

Study Officials

  • Weiming Liu, M.D.

    Beijing Tiantan Hospital

    PRINCIPAL INVESTIGATOR
  • Yuming Peng, M.D.

    Beijing Tiantan Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Liang Wu, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 7, 2023

First Posted

June 5, 2023

Study Start

April 1, 2024

Primary Completion

June 30, 2025

Study Completion

December 31, 2025

Last Updated

April 22, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations